These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24510338)

  • 1. The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium.
    Sander B; de Jong D; Rosenwald A; Xie W; Balagué O; Calaminici M; Carreras J; Gaulard P; Gribben J; Hagenbeek A; Kersten MJ; Molina TJ; Lee A; Montes-Moreno S; Ott G; Raemaekers J; Salles G; Sehn L; Thorns C; Wahlin BE; Gascoyne RD; Weller E
    Haematologica; 2014 Apr; 99(4):715-25. PubMed ID: 24510338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
    Richendollar BG; Pohlman B; Elson P; Hsi ED
    Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated prognostic pattern detection shows favourable diffuse pattern of FOXP3(+) Tregs in follicular lymphoma.
    Nelson LS; Mansfield JR; Lloyd R; Oguejiofor K; Salih Z; Menasce LP; Linton KM; Rose CJ; Byers RJ
    Br J Cancer; 2015 Oct; 113(8):1197-205. PubMed ID: 26439683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era.
    Blaker YN; Spetalen S; Brodtkorb M; Lingjaerde OC; Beiske K; Østenstad B; Sander B; Wahlin BE; Melen CM; Myklebust JH; Holte H; Delabie J; Smeland EB
    Br J Haematol; 2016 Oct; 175(1):102-14. PubMed ID: 27341313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patients.
    Xerri L; Huet S; Venstrom JM; Szafer-Glusman E; Fabiani B; Canioni D; Chassagne-Clément C; Dartigues-Cuilléres P; Charlotte F; Laurent C; Gelas-Dore B; Bolen CR; Punnoose E; Bouabdallah R; Brice P; Morschhauser F; Cartron G; Olive D; Salles G;
    Hum Pathol; 2017 Jun; 64():128-136. PubMed ID: 28414090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune infiltrate diversity confers a good prognosis in follicular lymphoma.
    Tsakiroglou AM; Astley S; Dave M; Fergie M; Harkness E; Rosenberg A; Sperrin M; West C; Byers R; Linton K
    Cancer Immunol Immunother; 2021 Dec; 70(12):3573-3585. PubMed ID: 33929583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages.
    Wahlin BE; Aggarwal M; Montes-Moreno S; Gonzalez LF; Roncador G; Sanchez-Verde L; Christensson B; Sander B; Kimby E
    Clin Cancer Res; 2010 Jan; 16(2):637-50. PubMed ID: 20068089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of tissue-infiltrating immune cells in tumor microenvironment of follicular lymphoma: A meta-analysis.
    Xie M; Jiang Q; Zhao S; Zhao J; Ye X; Qian W
    Int Immunopharmacol; 2020 Aug; 85():106684. PubMed ID: 32540726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
    Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium).
    de Jong D; Xie W; Rosenwald A; Chhanabhai M; Gaulard P; Klapper W; Lee A; Sander B; Thorns C; Campo E; Molina T; Hagenbeek A; Horning S; Lister A; Raemaekers J; Salles G; Gascoyne RD; Weller E
    J Clin Pathol; 2009 Feb; 62(2):128-38. PubMed ID: 18794197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma.
    Smeltzer JP; Jones JM; Ziesmer SC; Grote DM; Xiu B; Ristow KM; Yang ZZ; Nowakowski GS; Feldman AL; Cerhan JR; Novak AJ; Ansell SM
    Clin Cancer Res; 2014 Jun; 20(11):2862-72. PubMed ID: 24727328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols.
    de Jong D; Koster A; Hagenbeek A; Raemaekers J; Veldhuizen D; Heisterkamp S; de Boer JP; van Glabbeke M
    Haematologica; 2009 Jan; 94(1):70-7. PubMed ID: 19059937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium.
    Stevens WBC; Mendeville M; Redd R; Clear AJ; Bladergroen R; Calaminici M; Rosenwald A; Hoster E; Hiddemann W; Gaulard P; Xerri L; Salles G; Klapper W; Pfreundschuh M; Jack A; Gascoyne RD; Natkunam Y; Advani R; Kimby E; Sander B; Sehn LH; Hagenbeek A; Raemaekers J; Gribben J; Kersten MJ; Ylstra B; Weller E; de Jong D
    Haematologica; 2017 Aug; 102(8):1413-1423. PubMed ID: 28411252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
    Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
    Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular variant of peripheral T-cell lymphoma mimicking follicular lymphoma: a case report with a review of the Literature.
    Goto N; Tsurumi H; Sawada M; Kanemura N; Hara T; Kasahara S; Kito Y; Takada K; Sato Y; Yoshino T; Moriwaki H; Takami T
    Pathol Int; 2011 May; 61(5):326-30. PubMed ID: 21501301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass Cytometry of Follicular Lymphoma Tumors Reveals Intrinsic Heterogeneity in Proteins Including HLA-DR and a Deficit in Nonmalignant Plasmablast and Germinal Center B-Cell Populations.
    Wogsland CE; Greenplate AR; Kolstad A; Myklebust JH; Irish JM; Huse K
    Cytometry B Clin Cytom; 2017 Jan; 92(1):79-87. PubMed ID: 27933753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular lymphoma of compartmentalized small cleaved center cells and mantle zone lymphocytes. Evidence for a common derivation.
    Carbone A; Gloghini A; Volpe R; Attadia V; Gattei V; Zagonel V; Pinto A
    Am J Clin Pathol; 1992 Oct; 98(4):437-48. PubMed ID: 1384307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD1 distribution pattern, regardless of the cell origin, is an independent microenvironmental prognostic factor for progression-free survival in follicular lymphoma.
    Szumera-Ciećkiewicz A; Poleszczuk J; Kuczkiewicz-Siemion O; Paszkiewicz-Kozik E; Rymkiewicz G; Sokół K; Borysiuk A; Kotarska M; Kawecka M; Owczarek D; Pytlak B; Walewski J; Prochorec-Sobieszek M
    Pathol Res Pract; 2020 Oct; 216(10):153096. PubMed ID: 32853965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.
    Alonso-Álvarez S; Vidriales MB; Caballero MD; Blanco O; Puig N; Martin A; Peñarrubia MJ; Zato E; Galende J; Bárez A; Alcoceba M; Orfão A; González M; García-Sanz R
    Leuk Lymphoma; 2017 May; 58(5):1144-1152. PubMed ID: 27733075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.
    Carreras J; Lopez-Guillermo A; Roncador G; Villamor N; Colomo L; Martinez A; Hamoudi R; Howat WJ; Montserrat E; Campo E
    J Clin Oncol; 2009 Mar; 27(9):1470-6. PubMed ID: 19224853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.